Proton beam radiotherapy (PBR) for the treatment of retinal capillary haemangioblastoma stabilises tumour progression but with poor visual outcomes – (Eye Journal)
Proton beam radiotherapy (PBR) for the treatment of retinal capillary haemangioblastoma stabilises tumour progression but with poor visual outcomes Proton beam radiotherapy (PBR) for the treatment of retinal capillary haemangioblastoma stabilises tumour progression but with poor visual outcomes, Published online: 21 February 2019; doi:10.1038/s41433-019-0377-3 Proton beam radiotherapy (PBR) for the treatment of retinal capillary haemangioblastoma
An innovative visual acuity chart for urgent and primary care settings: validation of the Runge near vision card – (Eye Journal)
An innovative visual acuity chart for urgent and primary care settings: validation of the Runge near vision card An innovative visual acuity chart for urgent and primary care settings: validation of the Runge near vision card, Published online: 21 February 2019; doi:10.1038/s41433-019-0372-8 An innovative visual acuity chart for urgent and primary care settings: validation of
Ophthalmic Safety Alert- Do not use apraclonidine in infants below six months of age
The College has recently received a report from NHS Improvement of a severe adverse reaction in a six month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome. Two drops of apraclonidine 1% were administered to each eye, 30 minutes apart. Ninety minutes later the child had an acute
Position statement on the Associate Specialist grade
In April 2008 the ‘associate specialist’ (AS) grade was closed and succeeded by the new ‘specialty doctor’ grade. Over recent years there have been calls from the British Medical Association (BMA)1 and the Academy of Medical Royal Colleges (AoMRC)2 to reopen the AS grade. The Royal College of Ophthalmologists (RCOphth) works directly with the Staff
Detection of Papilloedema Study (DOPS): rates of false positive papilloedema in the community – (Eye Journal)
Detection of Papilloedema Study (DOPS): rates of false positive papilloedema in the community Detection of Papilloedema Study (DOPS): rates of false positive papilloedema in the community, Published online: 20 February 2019; doi:10.1038/s41433-019-0355-9 Detection of Papilloedema Study (DOPS): rates of false positive papilloedema in the community